19 results on '"Rokutanda, N."'
Search Results
2. Corrigendum to “78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)”: [Annals of Oncology 33 (2022) S1462-S1463]
3. 56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)
4. 57P Immune-mediated adverse event (imAE) incidence, timing and association with efficacy in the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in advanced biliary tract cancer (BTC)
5. O-1 Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
6. PD-8 Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
7. 831TiP - A phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1
8. 604 The Management of Papillary Lesions of the Breast Diagnosed Using Core Needle Biopsies
9. 481 Effect of Radiation Therapy on Local Control in Patients with Positive Surgical Margins After Breast-conserving Surgery
10. 429 Circulating Tumour Cells Before and After Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer
11. 289 Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Metastases
12. 288 Changes in Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2/neu Status During Primary Systemic Chemotherapy in Breast Cancer
13. 537 Changes of breast cancer incidence and trend among Japanese young women for the period 1972–2007
14. 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter
15. 166 Topoisomerase IIa expression correlates with prognostic factors in invasive breast cancer
16. 50 Neoadjuvant trastuzumab therapy with or without anthracycline containing chemotherapy for HER2-positive primary breast cancer
17. 53 Chemotherapy-induced amenorrhea and adjuvant endocrine therapy for premenopausal women with early breast cancer
18. Tamoxifen activates CYP3A4 and MDR-1 genes through steroid and xenobiotic receptor (SXR) in breast cancer cells
19. Potentiation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor (SXR) in breast cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.